Clinical Trial Update: U0289-401: Eight Week, Split-face, Study to Determine and Compare the Efficacy and Tolerability of MAXCLARITY™ II to PROACTIV™ [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating MAXCLARITY II versus PROACTIV for acne vulgaris has completed and results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Vulgaris

Drugs mentioned

• MAXCLARITY II
• PROACTIV

Snippet

Sponsor: Stiefel, a GSK Company | Conditions: Acne Vulgaris | Phase 4 | Status: COMPLETED | Results posted: 2017-06-20